ZeClinics
PrivateLast Round
Grant
Dec 20, 2022
Est. Valuation
$1.21M
Total Funding Raised
$3.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ZeClinics operates in Healthcare & Life Sciences and is based in Sant Feliu de Llobregat. Its latest recorded funding round was a Grant round in December 2022.
ZeClinics is a contract research organization (CRO) that provides preclinical services to accelerate research and development for the pharmaceutical, agrochemical, food, and cosmetic industries using zebrafish.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ZeClinics Comparables
Compare ZeClinics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zefit | 87% | |
| Magnitude Biosciences | 86% | |
| Hunter Biotechnology | 85% |
For institutional investors. Book with your work email.
ZeClinics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 20, 2022 | ||||
| Grant | Oct 19, 2022 | ||||
| Grant | Dec 7, 2016 | ||||
| Crowdfunding | May 31, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ZeClinics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Agencia Estatal de Investigación | Grant |
| European Commission | Grant |
| Pompeu Fabra University | Grant |
| NextGenerationEU | Grant |
| Capital Cell | Crowdfunding |
| Spanish Government (Ministry of Science) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
Open roles increased to 6, representing 29% of headcount.
- Dec 20, 2022
$726K grant received from Spanish Government and NextGenerationEU.
For institutional investors. Book with your work email.
ZeClinics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ZeClinics's valuation, stock price, and market status.
Is ZeClinics a public or private company?
ZeClinics is a private company.
What is the current stock price of ZeClinics?
ZeClinics is a private company, so its shares have no public market price. Caplight tracks ZeClinics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ZeClinics worth (valuation)?
ZeClinics's valuation is estimated at $1.2M based on funding round data.
Can I buy ZeClinics stock?
ZeClinics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ZeClinics's last funding round?
ZeClinics's most recent funding round was Grant on December 20, 2022.
Who are the main investors in ZeClinics?
Key investors in ZeClinics include European Innovation Council Fund, Agencia Estatal de Investigación, European Commission, Pompeu Fabra University, NextGenerationEU.
Will ZeClinics IPO soon?
No public IPO plans have been announced for ZeClinics.
How can I track ZeClinics secondary market activity?
Caplight tracks bids, offers, and trades in ZeClinics's shares on secondary markets.